יש סיכוי

בגיל 45 שנה ויותר הסיכוי להרות בכל מחזור הפריה נמוך מ- 1%.

ראי נתונים ממאמר מאוסטרליה שהתפרסם השבוע: Success rates AND cost of a live birth following fresh assisted reproduction treatment in women aged 45 years AND older, Australia 2002–2004 Elizabeth Sullivan1,3, Yueping Wang1, Michael Chapman2 AND Georgina Chambers1 Human Reproduction 2008 23(7):1639-1643; doi:10.1093/humrep/den102 BACKGROUND: The aim of this study was to calculate assisted reproductive technology (ART) success rates for fresh autologous AND donor cycles in women aged 45 AND the resultant cost per live birth. METHODS: We performed a retrospective population-based study of 2339 ART cycles conducted in Australia, 2002–2004 to women aged 45 years. The cost-outcome study was performed on fresh autologous treatment cycles. RESULTS: There were 1101 fresh autologous cycles initiated in women aged 45, with a pregnancy rate of 1.9 per 100 initiated cycles. There were 21 women who achieved a clinical pregnancy with 15 (71%) ending in early pregnancy loss AND 6 in live singleton births. The live birth rate following fresh autologous initiated cycles was 0.5% [95% confidence interval (CI): 0.1–1.0%]. Fresh donor recipients had an higher live birth rate of 19.1% (95% CI: 15.1–23.2) (odds ratio 43.2; 95% CI: 18.6–100.3) compared with women having fresh autologous cycles. The average cost of a live birth following fresh autologous cycles was 753 107. CONCLUSIONS: The success rate of fresh autologous treatment for women aged 45 years was <1%. The very high cost of a live birth reflects a treatment failure rate of >99%. The ART profession should counsel patients of the reality of the technology before the patients consent to treatment.